What are the Treatment Options for Aortic Stenosis?
What are the Treatment Options for Aortic Stenosis?
Why It Matters
Aortic stenosis can be life-threatening if left untreated. Learn about the treatments available to manage this condition effectively.
Contents
Surgical Interventions
For severe aortic stenosis, valve replacement surgery is often recommended. This involves replacing the narrowed valve with a prosthetic one to restore normal blood flow. There are two main types: mechanical valves, which last longer, and biological valves, which may require replacement after several years.
Less Invasive Options
For patients who are not good candidates for surgery, transcatheter aortic valve implantation (TAVI) is an option. This minimally invasive procedure involves inserting a new valve via a catheter, usually through the groin, and is suitable for patients with higher surgical risks.
Medical Management
In some cases, medications can help manage mild symptoms of aortic stenosis. These may include drugs to control blood pressure or reduce heart strain. However, medications do not cure the condition and are not a substitute for valve replacement.
FAQs
What is the main treatment for aortic stenosis?
Valve replacement surgery is the primary treatment.
Are there non-surgical options?
Yes, TAVI is a less invasive option for some patients.
Can medications cure aortic stenosis?
No, medications only manage symptoms, not the condition.
What are the types of prosthetic valves?
Mechanical and biological valves are the two main types.
The Bottom Line
Choosing the right treatment for aortic stenosis depends on the severity of the condition and the patient's overall health.
Additional References
- Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021; 143:e72.
- Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2022; 43:561.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic.